ELVN

Enliven Therapeutics, Inc.

NasdaqHealthcarePHARMACEUTICAL PREPARATIONS

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$00 buys
Total selling$424k2 sales
Net open-market−$424kBuying minus selling
Active insiders3Distinct reporting owners

ELVN transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Kunkel Lori Anne
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
Kunkel Lori Anne
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Derivative securitySEC filing ↗
$0View disclosure →
Kunkel Lori Anne
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$134kView disclosure →
Kunkel Lori Anne
Director
DIR
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SEC filing ↗
$4.19kView disclosure →
Hohl Benjamin
Chief Financial Officer
CFO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
Derivative securitySEC filing ↗
$0View disclosure →
Hohl Benjamin
Chief Financial Officer
CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Cluster sell
At least two distinct reporting owners sold within 14 days, with combined known value of at least $100k.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
+1
Pre-planned (10b5-1)

10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.

SEC filing ↗
−$232kView disclosure →
Hohl Benjamin
Chief Financial Officer
CFO
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
$89.4kView disclosure →
Collins Helen Louise
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
Derivative securitySEC filing ↗
$0View disclosure →
Collins Helen Louise
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Large sale
A sale above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
−$192kView disclosure →
Collins Helen Louise
CMO
CMO. Role codes can represent multiple titles; the list does not include the filing title.
Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Pre-planned (10b5-1)
10b5-1 plan language detected in footnotes; absence does not prove a discretionary trade.
SEC filing ↗
$12.4kView disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 3, 2026

Open-market transaction mix · 2 transactions in the selected period
0 buys0%·100%2 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026020$0$423,887.56−$423,887.56
Nov 2026000$0$0$0

Distinct insiders active

Reporting-owner CIKs by month · peak Oct 2026 (3)
Oct 2026: 3 insidersNov 2026: 0 insiders
Oct 2026Nov 2026
3distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
3 insiders
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy—
Largest sale$232k
10b5-1 detected6
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
10transactionstxns
  • M · Option exercise · dominant8 · 80%
  • S · Open-market sells2 · 20%

Activity by reported role

A joint filing can contribute to multiple roles
Director4
Chief financial officer3
CMO3

Reported Holdings After

Separated by insider, security, and ownership type

Hohl BenjaminCommon Stock · Direct
44.0k38.0kOct 19, 2026Oct 19, 2026
38,000Oct 19, 2026
Kunkel Lori AnneCommon Stock · Direct
52.9k45.6kOct 30, 2026Oct 30, 2026
52,925Oct 30, 2026
Kunkel Lori AnneStock Option (right to buy) · Direct
30.6k0Oct 30, 2026Oct 30, 2026
30,582Oct 30, 2026
Collins Helen LouiseStock Option (right to buy) · Direct
101k101kOct 19, 2026Oct 19, 2026
101,268Oct 19, 2026
Hohl BenjaminStock Option (right to buy) · Direct
175k175kOct 19, 2026Oct 19, 2026
175,000Oct 19, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
2 active days
Oct 16 → Nov 16
LessMore

Enliven Therapeutics, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Enliven Therapeutics, Inc.?

Kunkel Lori Anne, Hohl Benjamin, Collins Helen Louise.

When was the latest reported open-market purchase?

No code-P purchase is available for this period.

When was the latest reported open-market sale?

Hohl Benjamin reported a sale on Oct 19, 2026 valued at $232k. Read the SEC filing.

What is the recent purchase and sale balance?

Net open-market selling in the selected period was $423,887.56. Sales can occur for many non-investment reasons.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.